Back to funds

Prosight Management, LP

hedge fundUpdated 9 days ago

Managed by Prosight Management, Lp • Latest filing Q3 2026

Portfolio value
$515.5M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$483.9M
Q1 2026$609.8M
Q2 2026$580.4M
Q3 2026$515.5M

Top holdings

32 positions as of Q3 2026

View filing
G

LAKEFRONT BIOTHERAPEUTICS NV

Value
$59.3M
Shares
2.00M
% Port
11.49%
S

SHATTUCK LABS INC

Value
$52.2M
Shares
7.65M
% Port
10.12%
J

JANUX THERAPEUTICS INC

Value
$50.9M
Shares
2.94M
% Port
9.87%
N

NEKTAR THERAPEUTICS

Value
$47.5M
Shares
785.0K
% Port
9.22%
A

ABIVAX SA

Value
$37.3M
Shares
376.8K
% Port
7.24%
I

INSMED INC

Value
$27.2M
Shares
238.1K
% Port
5.27%
B

BOSTON SCIENTIFIC CORP

Value
$24M
Shares
550.0K
% Port
4.66%
I

IRHYTHM HOLDINGS INC

Value
$22.8M
Shares
201.0K
% Port
4.43%
A

ALKERMES PLC

Value
$22.3M
Shares
550.0K
% Port
4.32%
P

PRIVIA HEALTH GROUP INC

Value
$20.7M
Shares
1.05M
% Port
4.01%
M

MINERALYS THERAPEUTICS INC

Value
$20.1M
Shares
800.0K
% Port
3.90%
Z

ZYMEWORKS INC

Value
$19.1M
Shares
721.1K
% Port
3.71%
S

SYNDAX PHARMACEUTICALS INC

Value
$15.3M
Shares
812.6K
% Port
2.96%
K

KURA ONCOLOGY INC

Value
$13.7M
Shares
1.27M
% Port
2.65%
D

DENALI THERAPEUTICS INC

Value
$11.4M
Shares
550.7K
% Port
2.21%
P

PRAXIS PRECISION MEDICINES I

Value
$10.6M
Shares
36.4K
% Port
2.06%
H

HEALTHEQUITY INC

Value
$10.2M
Shares
115.8K
% Port
1.99%
B

BRIDGEBIO PHARMA INC

Value
$9.9M
Shares
150.0K
% Port
1.91%
A

ALNYLAM PHARMACEUTICALS INC

Value
$9.1M
Shares
37.0K
% Port
1.77%
H

HUMANA INC

Value
$8.4M
Shares
22.0K
% Port
1.63%

Explore